ORDER
REPRINTS
2190
Besbes and Ennigrou
(15 mmol) was added. The solution was stirred at reflux for the time indicated
in Table 1. When the epoxide disappearance was completed (monitored by
TLC), the solvent was removed and the residue was purified by flash chroma-
tography using CHCl3/EtOAc (7 : 3) as eluent. Compounds 2b–f and 3b were
crystallized from hexane.
Ethyl (Erythro)-3-phenyl-3-i-propylamino-2-hydroxypropionate (2b). IR
(CHCl3, n, cm21): 3525, 3331, 1731. 1H NMR (300 MHz CDCl3): 7.27
(m, 5H), 4.48 (d, 1H, J ¼ 4.2 Hz), 4.14 (d, 1H, J ¼ 4.2 Hz), 4.03 (q, 2H,
J ¼ 6.9 Hz), 2.90 (br, 2H, OH and NH), 2.68 (m, 1H), 1.12 (t, 3H,
J ¼ 6.9 Hz), 1.06 (d, 3H, J ¼ 6.6 Hz), 1.02 (d, 3H, J ¼ 5.8 Hz). 13C NMR
(75 MHz CDCl3): 172.7 (CO2), 138.1 (Carom), 128.3, 127.8, 127.7 (CHarom
)
73.4 (CHOH), 61.6 and 61.3 (PhCHN and CH2O), 45.1 (CH3CHN), 23.9
and 21.9 (2CH3CHN), 14.0 (CH3CH2O). M.S. m/z (%): 252 (MHþ, 0.5%),
178 (4), 148 (100), 106 (51), 91 (17), 79 (12.5). Anal. calcd. for
C14H21NO3 : C, 66.91; H, 8.42; N, 5.57. Found: C, 66.78; H, 8.50; N, 5.22.
Ethyl (Erythro)-3-phenyl-3-s-butylamino-2-hydroxypropionate (2c). IR
(CHCl3, n, cm21): 3525, 3336, 1731. 1H NMR (300 MHz CDCl3): 7.25
(m, 5H), 4.50 and 4.48 (2d, 1H, J ¼ 4.2 Hz), 4.17 and 4.15 (2d, 1H,
J ¼ 4.2 Hz), 4.02 (m, 2H) 3.60 (br, 2H, OH and NH), 2.53 and 2.41 (2m,
1H), 1.57–1.29 (m, 2H), 1.12 and 1.11 (2t, 3H, J ¼ 6.9 Hz), 1.04 and 0.97
(2d, 3H, J ¼ 6.2 Hz), 0.87 and 0.86 (2t, 3H, J ¼ 7.3 Hz). 13C NMR (75 MHz
CDCl3): 172.5 (CO2), 138.3, and 137.8, (Carom), 128.2, 127.7, 127.6 (CHarom),
73.5 and 72.9 (CHOH), 61.5, 61.3, 61.1, 61.0 (PHCHN and CH2O), 51.0 and
50.7 (CH3CHN), 30.3 and 28.4 (CH3CH2CH), 20.3 and 19.0 (CH3CHN), 13.9
(CH3CH2O), 10.3 and 9.6 (CH3CH2CH). M.S. m/z (%): 266 (MHþ, 1%), 236
(2), 192 (3), 162 (100), 106 (70), 91 (29), 79 (15), 77 (9.5). Anal. calcd. for
C15H23NO3:C, 67.90; H, 8.74; N, 5.28. Found: C, 67.02; H, 8.67; N, 5.27.
Ethyl (Erythro)-3-phenyl-3-(a-methylbenzyl)amino-2-hydroxypropio-
nate (2d). IR (CHCl3, n, cm21): 3520, 3336, 1728. 1H NMR (300MHz
CDCl3): 7.30 (m, 10H), 4.40 (d, 1H, J ¼ 4.2 Hz), 3.97 (m, 2H) 3.76 (d, 1H,
J ¼ 4.2 Hz), 3.55 (q, 1H, J ¼ 6.6 Hz), 3.06 (br, 2H, OH and NH), 1.33 (d, 3H,
J ¼ 6.6 Hz), 1.05 (t, 3H, J ¼ 6.9 Hz). 13C NMR (75 MHz CDCl3): 172.5 (CO2),
144.5, and 137.8, (2Carom), 128.4, 128.3, 128.1, 127.7, 127.0, 126.9 126.6
(CHarom), 73.8 (CHOH), 61.6 and 61.2 (PhCHN and CH2O), 54.6 (CH3CHN),
25.0 (CH3CHN), 13.8 (CH3CH2O). M.S. m/z (%): 209 (93), 208 (43), 194 (77),
165 (13), 105 (100), 91 (12), 89 (24), 79 (30.5), 77 (68.5). Anal. calcd. for
C19H23NO3: C, 72.82; H, 7.40; N, 4.47. Found: C, 72.61; H, 7.32; N, 4.55.
Ethyl (Erythro)-3-phenyl-3-cyclohexylamino-2-hydroxypropionate
1
(2e). IR (CHCl3, n, cm21): 3520, 3328, 1728. H NMR (300 MHz CDCl3):
7.28 (m, 5H), 4.51 (d, 1H, J ¼ 4.2 Hz), 4.22 (d, 1H, J ¼ 4.2 Hz), 4.02
(q, 2H, J ¼ 6.9 Hz), 3.10 (br, 2H, OH and NH), 2.36–1.18 (m, 11H), 1.10
(t, 3H, J ¼ 6.9 Hz). 13C NMR (75 MHz CDCl3): 172.6 (CO2), 138.3 (Carom),